NASDAQ · UFO
Procure Space ETF
$40.24-$1.48 (-3.55%)
Procure Space ETF’s quoted price sits in the lower half of its reported 52-week range, 41.01% below the high.
Loading market information…
AMEX · UPGD · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Invesco Bloomberg Analyst Rating Improvers ETF’s quoted price sits in the upper half of its reported 52-week range, 2.56% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Invesco Bloomberg Analyst Rating Improvers ETF’s forward annual dividend is $1.29 per share, paid annual. The forward yield is 1.57% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Invesco Bloomberg Analyst Rating Improvers ETF, ticker symbol UPGD, is an investment vehicle designed to track the performance of the Bloomberg ANR Improvers Index. This exchange-traded fund typically commits at least 90% of its total holdings to the securities that comprise its underlying index. The index itself identifies the top 50 companies from the Bloomberg US Large Mid Universe that have shown the greatest improvement in analyst recommendations over the preceding six- and twelve-month periods. Both the index and the fund are rebalanced quarterly, specifically in March, June, September, and December. As of March 25, 2024, the fund underwent several significant changes. It was formerly known as the Invesco Raymond James SB-1 Equity ETF (RYJ). The fund's name, ticker symbol, and underlying index provider shifted from Raymond James Research Services, LLC to Bloomberg Index Services Limited. Consequently, its benchmark index changed from the Raymond James SB-1 Equity Index to the Bloomberg ANR Improvers Index. These adjustments also redefined the fund's investment objective and core strategy to mirror the performance of the new Bloomberg ANR Improvers Index by investing a minimum of 90% of its assets in its constituents. Additionally, a prior non-fundamental policy, which mandated investing at least 80% of assets in securities implied by its former name, was removed. Concurrently, the annual management fee for the fund was reduced from 0.75% to a lower rate of 0.40%. For more detailed information, please refer to the fund's prospectus.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:40 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$40.24-$1.48 (-3.55%)
Procure Space ETF’s quoted price sits in the lower half of its reported 52-week range, 41.01% below the high.
$61.30-$0.02 (-0.03%)
Invesco S&P 500 Enhanced Value ETF’s quoted price sits in the upper half of its reported 52-week range, 1.65% below the high.
$36.33-$0.26 (-0.71%)
AllianzIM U.S. Equity Buffer20 Feb ETF’s quoted price sits in the upper half of its reported 52-week range, 0.9% below the high.
$35.93-$0.92 (-2.49%)
Argent Mid Cap ETF’s quoted price sits in the upper half of its reported 52-week range, 4.99% below the high.
$47.99-$0.44 (-0.92%)
Goldman Sachs ActiveBeta Europe Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.59% below the high.
$17.62-$0.18 (-1.01%)
KraneShares MSCI All China Health Care Index ETF’s quoted price sits in the upper half of its reported 52-week range, 11.59% below the high.
$38.45+$0.65 (+1.73%)
Rayliant Quantitative Developed Market Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 7.12% below the high.
$39.27+$0.21 (+0.54%)
Pacer Industrial Real Estate ETF’s quoted price sits in the lower half of its reported 52-week range, 8.76% below the high.
